Revolution Medicines, Inc.RVMDNASDAQ
Loading
SG&A Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+68.1%
5Y CAGR+55.2%
Studio
Year-over-Year Change

Selling, general, and administrative expenses

3Y CAGR
+68.1%/yr
vs +44.1%/yr prior
5Y CAGR
+55.2%/yr
Recent acceleration
Acceleration
+24.0pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
9x
Strong expansion
Streak
8 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM$192.67M+98.0%
2024$97.30M+28.7%
2023$75.62M+86.3%
2022$40.59M+33.3%
2021$30.45M+42.1%
2020$21.43M+72.7%
2019$12.41M+31.8%
2018$9.41M+107.1%
2017$4.54M-